Jia-Hong Chen

512 total citations
29 papers, 383 citations indexed

About

Jia-Hong Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jia-Hong Chen has authored 29 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 9 papers in Surgery. Recurrent topics in Jia-Hong Chen's work include Prostate Cancer Treatment and Research (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Peptidase Inhibition and Analysis (3 papers). Jia-Hong Chen is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Peptidase Inhibition and Analysis (3 papers). Jia-Hong Chen collaborates with scholars based in Taiwan, China and United States. Jia-Hong Chen's co-authors include Yi‐Ying Wu, Ching‐Liang Ho, Tzu‐Chuan Huang, Tsu‐Yi Chao, Zhuoyuan Lin, Huichan He, Xiaohui Ling, Xin Fu, Zhaodong Han and Weide Zhong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jia-Hong Chen

25 papers receiving 378 citations

Peers

Jia-Hong Chen

ONCOL

PRM

PFM

Bryan J. Thibodeau United States

Wei‐Hwa Lee Taiwan

T. Christopher Windham United States

Eric Schordan France

Astrid Grottke Germany

Yanqiu Song China

Agnese Di Rocco United States

Iwona Gisterek Poland

Jennifer H. Benbow United States

Didem Taştekin Türkiye

Bryan J. Thibodeau United States

Jia-Hong Chen

206 ×1.1

103 ×0.9

ONCOL

110 ×1.1

PRM

63 ×0.9

31 ×0.6

PFM

Citations per year, relative to Jia-Hong Chen Jia-Hong Chen (= 1×) peers Bryan J. Thibodeau

Countries citing papers authored by Jia-Hong Chen

Since Specialization

Citations

This map shows the geographic impact of Jia-Hong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia-Hong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia-Hong Chen more than expected).

Fields of papers citing papers by Jia-Hong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia-Hong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia-Hong Chen. The network helps show where Jia-Hong Chen may publish in the future.

Co-authorship network of co-authors of Jia-Hong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jia-Hong Chen. A scholar is included among the top collaborators of Jia-Hong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia-Hong Chen. Jia-Hong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Pau‐Chung, et al.. (2025). Tegafur-uracil as a Maintenance Therapy for Non-metastatic Nasopharyngeal Carcinoma: Insights from the Literature. Anticancer Research. 45(9). 3617–3628.

Zeng, Jie, Jia-Hong Chen, Chuanfan Zhong, et al.. (2023). Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer. Frontiers in Pharmacology. 14. 1191129–1191129. 1 indexed citations

Wu, Alexander T.H., Gaber El‐Saber Batiha, Ching‐Liang Ho, et al.. (2022). Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin. Biology. 11(2). 324–324. 7 indexed citations

Shih, Ming‐Lang, Jih‐Chin Lee, Bashir Lawal, et al.. (2022). Transcriptomic discovery of a theranostic signature (SERPINE1/MMP3/COL1A1/SPP1) for head and neck squamous cell carcinomas and identification of antrocinol as a candidate drug. Computers in Biology and Medicine. 150. 106185–106185. 4 indexed citations

Han, Zhaodong, Yuanfa Feng, Yulin Deng, et al.. (2022). Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer. Translational Andrology and Urology. 11(7). 914–928. 7 indexed citations

Huang, Wen‐Yen, Ching‐Liang Ho, Tsu‐Yi Chao, Jih‐Chin Lee, & Jia-Hong Chen. (2021). Oral tegafur-uracil as a metronomic therapy in stage IVa and IVb cancer of the oral cavity. American Journal of Otolaryngology. 42(6). 103156–103156. 5 indexed citations

Wang, Chih‐Wei, et al.. (2020). Application of Color Doppler Ultrasound to Evaluate Chemotherapeutic Effect on Primary Thyroid Lymphoma. Journal of Medical Ultrasound. 29(1). 60–63. 2 indexed citations

Lee, Cho‐Hao, Chin Lin, Tzu‐Chuan Huang, et al.. (2018). Premorbid BMI as a prognostic factor in small-cell lung cancer—a single institute experience. Oncotarget. 9(37). 24642–24652. 10 indexed citations

Huang, Wen‐Yen, Ching‐Liang Ho, Chia‐Cheng Lee, et al.. (2017). Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer. PLoS ONE. 12(3). e0174280–e0174280. 19 indexed citations

10.

Huang, I‐Hsuan, Yi‐Ying Wu, Tzu‐Chuan Huang, Wei‐Kuo Chang, & Jia-Hong Chen. (2016). Statistics and outlook of primary hepatic angiosarcoma based on clinical stage. Oncology Letters. 11(5). 3218–3222. 15 indexed citations

11.

Lai, Shiue‐Wei, Kuan‐Yu Chen, Jia-Hong Chen, & Ching‐Liang Ho. (2015). Multiple Spinal and Bone Metastases as the Initial Presentation of Small Cell Carcinoma of the Prostate. SHILAP Revista de lepidopterología.

12.

Ko, Kai‐Hsiung, Hsian‐He Hsu, Hong‐Wei Gao, et al.. (2015). Predictive Value of 18F-FDG PET and CT Morphologic Features for Recurrence in Pathological Stage IA Non-Small Cell Lung Cancer. Medicine. 94(3). e434–e434. 16 indexed citations

13.

Chen, Jia-Hong, Tzu‐Chuan Huang, Yi‐Ying Wu, et al.. (2015). Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma. PLoS ONE. 10(6). e0128905–e0128905. 7 indexed citations

14.

Huang, Tzu‐Chuan, Yi‐Ying Wu, Yuguang Chen, et al.. (2015). Discrimination Index of Microcytic Anemia in Young Soldiers: A Single Institutional Analysis. PLoS ONE. 10(2). e0114061–e0114061. 23 indexed citations

15.

Chang, Ping‐Ying, et al.. (2015). Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70. PLoS ONE. 10(9). e0138632–e0138632. 9 indexed citations

16.

Chen, Yuguang, Jia-Hong Chen, & Tzu‐Chuan Huang. (2014). Tension Pneumoperitoneum in a Lung Cancer Patient with Intestinal Metastases. Journal of Emergency Medicine. 48(1). e23–e24. 3 indexed citations

17.

Chen, Jia-Hong, Tzu‐Chuan Huang, Yi‐Ying Wu, et al.. (2014). Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era. Leukemia & lymphoma. 56(7). 2047–2055. 21 indexed citations

18.

Huang, Yaqiang, Zhaodong Han, Yuxiang Liang, et al.. (2013). Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer. Medical Oncology. 31(1). 820–820. 43 indexed citations

19.

Tang, Wenhao, et al.. (2011). Near Total Regression of Diffuse Brain Metastases in Adenocarcinoma of the Lung with an EGFR Exon 19 Mutation: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 4(3). 445–451. 2 indexed citations

20.

Chen, Jia-Hong, Ping‐Ying Chang, & Nai‐Shun Yao. (2009). Gemcitabine Plus Vinorelbine as an Effective Salvage Chemotherapeutic Regimen in Cisplatin-Refractory Germ Cell Tumor. Southern Medical Journal. 102(5). 546–548. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact